Ecully, France

Tino Krell


Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
3 patents (USPTO):

Title: The Innovations of Inventor Tino Krell

Introduction

Tino Krell, a prominent inventor based in Ecully, France, has made significant contributions to the field of biomedical research, particularly focusing on HIV-related therapies. With a total of three patents to his name, Krell's work showcases his dedication to medical innovation and the development of effective solutions to combat viral infections.

Latest Patents

Among Tino Krell's latest patents are groundbreaking methods aimed at inducing HIV-neutralizing antibodies. One notable patent describes a method for inducing antibodies that can neutralize HIV primary isolates in mammals through the administration of a specific pharmaceutical composition. This composition includes a polypeptide represented by the formula N-L-C. Another important patent focuses on providing a polypeptide capable of forming a structure that mimics the intermediate of gp41, which serves as a pivotal component in the development of vaccines for treating or preventing HIV infections.

Career Highlights

Krell's career is marked by his role at Aventis Pasteur S.A., a leading company in the field of vaccines and biologics. His work not only reflects his commitment to scientific advancement but also his ability to translate complex biomedical concepts into viable therapeutic solutions that can benefit public health.

Collaborations

Throughout his career, Tino Krell has collaborated with notable colleagues, including Michel Chevalier and Florence Boudet. These partnerships have allowed for the exchange of ideas and integration of diverse expertise, further propelling advancements in their shared research objectives.

Conclusion

In summary, Tino Krell stands out as an influential inventor with a focus on developing innovative methods for combating HIV. His patents and collaborative efforts underscore the important intersection of science and technology in addressing some of the most pressing health challenges of our time. As advancements in medical research continue to evolve, Krell's contributions will likely play a crucial role in shaping future vaccine development and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…